Advancing vaccine development through green biotechnology

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Occupational exposure to reinforced concrete production is associated with adverse respiratory health

The exposure to fine particulate matter (PM) in reinforced concrete production.

September 21, 2023

The federal research funding freeze holds the lifeblood of medical research ransom

When I read the recent news that the Trump administration has frozen all federally funded grants and loans to researchers like me, it felt like

January 28, 2025

MASCT by Hengrui Yuanzheng Biotechnology for Metastatic Colorectal Cancer: Likelihood of Approval

MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Metastatic Colorectal Cancer.

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.